MAI Wealth Advisors »

Lineage Cell Therapeutics In shares owned by MAI Wealth Advisors

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by MAI Wealth Advisors from 13F filings

Historical chart of MAI Wealth Advisors investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by MAI Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by MAI Wealth Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $876k 804k 1.09
2023-09-30 $1.1M 955k 1.18
2023-06-30 $1.3M 952k 1.41
2023-03-31 $638k 425k 1.50
2022-12-31 $535k 457k 1.17
2022-09-30 $590k 522k 1.13
2022-06-30 $391k 248k 1.58